Sirona Biochem Corp.
SRBCF
$0.0418
$0.000.00%
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -119.01% | -101.54% | -94.83% | -95.06% | -88.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -119.01% | -101.54% | -94.83% | -95.06% | -88.23% |
| Cost of Revenue | 15.69% | 15.69% | 122.64% | 203.85% | 106.06% |
| Gross Profit | -184.32% | -105.92% | -99.33% | -99.59% | -91.94% |
| SG&A Expenses | -10.06% | -22.06% | -25.55% | -61.83% | -55.47% |
| Depreciation & Amortization | 5.71% | 4.29% | 4.29% | 2.82% | -1.41% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.10% | -26.61% | -11.95% | -45.32% | -49.59% |
| Operating Income | -8.06% | -1.92% | -16.59% | 35.56% | 41.84% |
| Income Before Tax | -15.67% | -7.10% | -20.73% | 32.31% | 38.42% |
| Income Tax Expenses | 333.33% | 300.00% | -121.95% | -114.89% | -120.45% |
| Earnings from Continuing Operations | -15.85% | -7.13% | -20.37% | 32.45% | 38.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.85% | -7.13% | -20.37% | 32.45% | 38.56% |
| EBIT | -8.06% | -1.92% | -16.59% | 35.56% | 41.84% |
| EBITDA | -8.40% | -1.60% | -16.36% | 35.83% | 42.12% |
| EPS Basic | -11.76% | -4.69% | -16.67% | 35.65% | 39.82% |
| Normalized Basic EPS | -14.29% | -7.69% | -20.00% | 35.21% | 40.00% |
| EPS Diluted | -11.76% | -4.69% | -16.67% | 35.65% | 39.82% |
| Normalized Diluted EPS | -14.29% | -7.69% | -20.00% | 35.21% | 40.00% |
| Average Basic Shares Outstanding | 2.75% | 2.14% | 2.23% | 3.16% | 1.33% |
| Average Diluted Shares Outstanding | 2.75% | 2.14% | 2.23% | 3.16% | 1.33% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
